Advanced Cell Diagnostics

Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell-based and tissue-based diagnostic assays for personalized medicine. ACD’s products and services are based on its proprietary RNAscope® technology – the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ with single-molecule sensitivity. ACD technology is used for proprietary diagnostic tests to manage cancer and to validate biomarkers for targeted therapeutic drug development.